Russia announced on Saturday that it has completed clinical trials on the Russian vaccine against the coronavirus that causes the “Covid-19” disease, revealing that it is planning a massive vaccination campaign among the population.
The Russian vaccine: the success of human trials
The Russian “TAS” agency quoted the Minister of Health, Mikhail Murashko, as saying that the gamaliel center for virology and biotechnology had completed the clinical trials of the Russian vaccine.
He added that they are focusing on obtaining the Russian vaccine public safety approvals.
Russia has previously announced that it hopes that the Russian vaccine it is developing will be the first vaccine to obtain international approval, after tests and clinical trials have ended.
And the Russian vaccine is not the only one that has developed Russia against Coronavirus, as more than 150 worshipers around the world are currently being developed and tested, but it has not received widespread approval to use it yet.
The Russian minister said that the government center is currently working on developing another vaccine against the Coronavirus, and has entered the stages of clinical trials.
Clinical trials are a term that means that the vaccine has been tested in humans
And the Russian Health Ministry expects there are other vaccine developers who will ask for approval for clinical trials on some of the volunteers within the next 6-8 weeks.
And the “RIA Novosti” agency quoted Murashko as saying that Moscow wants to conduct a large-scale vaccination campaign for the Russian vaccine next October.
The minister did not specify which vaccine would be used in the vaccination process, but confirmed the preparation of lists of beneficiaries of the Russian vaccine.
He said that the first beneficiaries to receive the vaccination are doctors and teachers.
On Saturday, Russia recorded 95 new deaths, raising the death toll in the country to more than 14,000.